Royalty Pharma (RPRXN) Q2 2023 Earnings Report
1 Followers
MX:RPRXN Q2 2023 EPS Results
- Actual EPS
- MXN 15.68
- Consensus EPS
- MXN 15.40
- Beat/Miss
- Beat by +MXN 0.28
- One Year Ago EPS
- MXN 15.05
MX:RPRXN Q2 2023 Revenue Results
- Actual Revenue
- MXN 9.99B
- Expected Revenue
- MXN 10.09B
- Beat/Miss
- Missed by -MXN 101.95M
- YoY Revenue Growth
- +0.42%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/08/2023
- Time
- Before Open
- Conference Call
- Tuesday, August 8, 2023
MX:RPRXN Upcoming Earnings
Royalty Pharma's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
MX:RPRXN Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:RPRXN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2026 (Q4) | 29.06- | 27.2 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 21.9122.42 | 21.77 | 2.98% (+0.65) | |
| Aug 05, 2026 | 2026 (Q2) | 23.6224.51 | 21.17 | 15.78% (+3.34) | |
| May 06, 2026 | 2026 (Q1) | 22.5324.05 | 13.9 | 73.03% (+10.15) | |
| Feb 11, 2026 | 2025 (Q4) | 23.8627.20 | 21.36 | 27.37% (+5.85) | |
| Nov 05, 2025 | 2025 (Q3) | 18.4421.77 | 17.02 | 27.92% (+4.75) | |
| Aug 06, 2025 | 2025 (Q2) | 19.1521.17 | 17.83 | 18.73% (+3.34) | |
| May 08, 2025 | 2025 (Q1) | 17.6813.90 | 18.15 | -23.42% (-4.25) | |
| Feb 11, 2025 | 2024 (Q4) | 19.5821.36 | 21.32 | 0.17% (+0.04) | |
| Nov 06, 2024 | 2024 (Q3) | 17.2017.02 | 14.64 | 16.22% (+2.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
